In our study, an effective method was provided to evaluate the prognostic value of de novo lipogenesis-related genes in HCC by constructing a novel prognostic risk prediction model including G6PD, LCAT, SERPINE1, SOAT2, CYP2C9, and UGT1A10. This evidence concerns the gene SOAT2 and hepatocellular carcinoma.